Literature DB >> 10381496

Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor.

J H Jansen1, M C de Ridder, W M Geertsma, C A Erpelinck, K van Lom, E M Smit, R Slater, B A vd Reijden, G E de Greef, P Sonneveld, B Löwenberg.   

Abstract

The combined use of retinoic acid and chemotherapy has led to an important improvement of cure rates in acute promyelocytic leukemia. Retinoic acid forces terminal maturation of the malignant cells and this application represents the first generally accepted differentiation-based therapy in leukemia. Unfortunately, similar approaches have failed in other types of hematological malignancies suggesting that the applicability is limited to this specific subgroup of patients. This has been endorsed by the notorious lack of response in acute promyelocytic leukemia bearing the variant t(11;17) translocation. Based on the reported synergistic effects of retinoic acid and the hematopoietic growth factor granulocyte colony-stimulating factor (G-CSF), we studied maturation of t(11;17) positive leukemia cells using several combinations of retinoic acid and growth factors. In cultures with retinoic acid or G-CSF the leukemic cells did not differentiate into mature granulocytes, but striking granulocytic differentiation occurred with the combination of both agents. At relapse, the patient was treated with retinoic acid and G-CSF before reinduction chemotherapy. With retinoic acid and G-CSF treatment alone, complete granulocytic maturation of the leukemic cells occurred in vivo, followed by a complete cytogenetical and hematological remission. Bone marrow and blood became negative in fluorescense in situ hybridization analysis and semi-quantitative polymerase chain reaction showed a profound reduction of promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion transcripts. This shows that t(11;17) positive leukemia cells are not intrinsically resistant to retinoic acid, provided that the proper costimulus is administered. These observations may encourage the investigation of combinations of all-trans retinoic acid and hematopoietic growth factors in other types of leukemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381496

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.

Authors:  Lei Wang; Murat O Arcasoy; Stephanie S Watowich; Bernard G Forget
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

2.  New role for granulocyte colony-stimulating factor-induced extracellular signal-regulated kinase 1/2 in histone modification and retinoic acid receptor α recruitment to gene promoters: relevance to acute promyelocytic leukemia cell differentiation.

Authors:  B Cassinat; F Zassadowski; C Ferry; L Llopis; N Bruck; E Lainey; V Duong; A Cras; G Despouy; O Chourbagi; G Beinse; P Fenaux; C Rochette Egly; C Chomienne
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

3.  Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.

Authors:  E M Rego; L Z He; R P Warrell; Z G Wang; P P Pandolfi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation.

Authors:  Bo Jiao; Zhi-Hong Ren; Ping Liu; Li-Juan Chen; Jing-Yi Shi; Ying Dong; Julien Ablain; Lin Shi; Li Gao; Jun-Pei Hu; Rui-Bao Ren; Hugues de Thé; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

5.  Large-scale identification of disease genes involved in acute myeloid leukemia.

Authors:  Stefan J Erkeland; Marijke Valkhof; Claudia Heijmans-Antonissen; Antoinette van Hoven-Beijen; Ruud Delwel; Mirjam H A Hermans; Ivo P Touw
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 6.  Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.

Authors:  J W Zhang; J Y Wang; S J Chen; Z Chen
Journal:  J Biosci       Date:  2000-09       Impact factor: 2.795

7.  Dry-reagent disposable dipstick test for visual screening of seven leukemia-related chromosomal translocations.

Authors:  Despina P Kalogianni; Vasiliki Bravou; Theodore K Christopoulos; Penelope C Ioannou; Nicholas C Zoumbos
Journal:  Nucleic Acids Res       Date:  2007-01-23       Impact factor: 16.971

8.  Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia.

Authors:  Stephen E Langabeer; Lisa Preston; Johanna Kelly; Matt Goodyer; Ezzat Elhassadi; Amjad Hayat
Journal:  Case Rep Hematol       Date:  2017-04-26

Review 9.  Characterization of atypical acute promyelocytic leukaemia: Three cases report and literature review.

Authors:  Xiaoxue Wang; Jing Wang; Lijun Zhang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 10.  Granulocyte colony-stimulating factor and leukemogenesis.

Authors:  Lorena Lobo de Figueiredo; Rodrigo Siqueira de Abreu e Lima; Eduardo Magalhães Rego
Journal:  Mediators Inflamm       Date:  2004-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.